Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 696 entries
Sorted by: Best Match Show Resources per page
Temporal variations in stump pressure and assessment of images obtained from cone-beam computed tomography during balloon-occluded transarterial chemoembolization.

Hepatology research : the official journal of the Japan Society of Hepatology

Kakuta A, Shibutani K, Ono S, Miura H, Tsushima F, Kakehata S, Basaki K, Fujita H, Seino H, Fujita T, Takai Y.
PMID: 26333025
Hepatol Res. 2016 Mar;46(5):468-76. doi: 10.1111/hepr.12579. Epub 2015 Nov 05.

AIM: Balloon-occluded transcatheter arterial chemoembolization (B-TACE) was used to show the optimized duration of balloon occlusion to start injection of lipiodol in order to maximize lipiodol deposition in the nodule, and to reveal the endpoint of lipiodol injection.METHODS: Of...

Cite
Kakuta A, Shibutani K, Ono S, et al. Temporal variations in stump pressure and assessment of images obtained from cone-beam computed tomography during balloon-occluded transarterial chemoembolization. Hepatol Res. 2015;46(5):468-76doi: 10.1111/hepr.12579.
Kakuta, A., Shibutani, K., Ono, S., Miura, H., Tsushima, F., Kakehata, S., Basaki, K., Fujita, H., Seino, H., Fujita, T., & Takai, Y. (2016). Temporal variations in stump pressure and assessment of images obtained from cone-beam computed tomography during balloon-occluded transarterial chemoembolization. Hepatology research : the official journal of the Japan Society of Hepatology, 46(5), 468-76. https://doi.org/10.1111/hepr.12579
Kakuta, Akihisa, et al. "Temporal variations in stump pressure and assessment of images obtained from cone-beam computed tomography during balloon-occluded transarterial chemoembolization." Hepatology research : the official journal of the Japan Society of Hepatology vol. 46,5 (2016): 468-76. doi: https://doi.org/10.1111/hepr.12579
Kakuta A, Shibutani K, Ono S, Miura H, Tsushima F, Kakehata S, Basaki K, Fujita H, Seino H, Fujita T, Takai Y. Temporal variations in stump pressure and assessment of images obtained from cone-beam computed tomography during balloon-occluded transarterial chemoembolization. Hepatol Res. 2016 Mar;46(5):468-76. doi: 10.1111/hepr.12579. Epub 2015 Nov 05. PMID: 26333025.
Copy Download .nbib Format: NLM
A case of pulmonary thromboembolism due to coagulation factor V Leiden in Japan ~ usefulness of next generation sequencing~.

Thrombosis journal

Sueta D, Ito M, Uchiba M, Sakamoto K, Yamamoto E, Izumiya Y, Kojima S, Kaikita K, Shinriki S, Hokimoto S, Matsui H, Tsujita K.
PMID: 28293147
Thromb J. 2017 Mar 14;15:8. doi: 10.1186/s12959-017-0132-6. eCollection 2017.

BACKGROUND: Because the venous thromboembolisms (VTEs) due to the coagulation factor V R506Q (FV Leiden) mutation is often seen in Caucasians, the VTE onset in Japan has not been reported.CASE PRESENTATION: A 34-year-old man from north Africa experiencing sudden...

Cite
Sueta D, Ito M, Uchiba M, et al. A case of pulmonary thromboembolism due to coagulation factor V Leiden in Japan ~ usefulness of next generation sequencing~. Thromb J. 2017;15:8doi: 10.1186/s12959-017-0132-6.
Sueta, D., Ito, M., Uchiba, M., Sakamoto, K., Yamamoto, E., Izumiya, Y., Kojima, S., Kaikita, K., Shinriki, S., Hokimoto, S., Matsui, H., & Tsujita, K. (2017). A case of pulmonary thromboembolism due to coagulation factor V Leiden in Japan ~ usefulness of next generation sequencing~. Thrombosis journal, 158. https://doi.org/10.1186/s12959-017-0132-6
Sueta, Daisuke, et al. "A case of pulmonary thromboembolism due to coagulation factor V Leiden in Japan ~ usefulness of next generation sequencing~." Thrombosis journal vol. 15 (2017): 8. doi: https://doi.org/10.1186/s12959-017-0132-6
Sueta D, Ito M, Uchiba M, Sakamoto K, Yamamoto E, Izumiya Y, Kojima S, Kaikita K, Shinriki S, Hokimoto S, Matsui H, Tsujita K. A case of pulmonary thromboembolism due to coagulation factor V Leiden in Japan ~ usefulness of next generation sequencing~. Thromb J. 2017 Mar 14;15:8. doi: 10.1186/s12959-017-0132-6. eCollection 2017. PMID: 28293147; PMCID: PMC5348750.
Copy Download .nbib Format: NLM
Positron emission tomography to elucidate pharmacokinetic differences of regioisomeric retinoid x receptor agonists.

ACS medicinal chemistry letters

Kobayashi T, Furusawa Y, Yamada S, Akehi M, Takenaka F, Sasaki T, Akahoshi A, Hanada T, Matsuura E, Hirano H, Tai A, Kakuta H.
PMID: 25815156
ACS Med Chem Lett. 2015 Jan 20;6(3):334-8. doi: 10.1021/ml500511m. eCollection 2015 Mar 12.

RXR partial agonist NEt-4IB (2a, 6-[ethyl-(4-isobutoxy-3-isopropylphenyl)amino]pyridine-3-carboxylic acid: EC50 = 169 nM, E max = 55%) showed a blood concentration higher than its E max after single oral administration at 30 mg/kg to mice, and repeated oral administration at 10...

Cite
Kobayashi T, Furusawa Y, Yamada S, et al. Positron emission tomography to elucidate pharmacokinetic differences of regioisomeric retinoid x receptor agonists. ACS Med Chem Lett. 2015;6(3):334-8doi: 10.1021/ml500511m.
Kobayashi, T., Furusawa, Y., Yamada, S., Akehi, M., Takenaka, F., Sasaki, T., Akahoshi, A., Hanada, T., Matsuura, E., Hirano, H., Tai, A., & Kakuta, H. (2015). Positron emission tomography to elucidate pharmacokinetic differences of regioisomeric retinoid x receptor agonists. ACS medicinal chemistry letters, 6(3), 334-8. https://doi.org/10.1021/ml500511m
Kobayashi, Toshiki, et al. "Positron emission tomography to elucidate pharmacokinetic differences of regioisomeric retinoid x receptor agonists." ACS medicinal chemistry letters vol. 6,3 (2015): 334-8. doi: https://doi.org/10.1021/ml500511m
Kobayashi T, Furusawa Y, Yamada S, Akehi M, Takenaka F, Sasaki T, Akahoshi A, Hanada T, Matsuura E, Hirano H, Tai A, Kakuta H. Positron emission tomography to elucidate pharmacokinetic differences of regioisomeric retinoid x receptor agonists. ACS Med Chem Lett. 2015 Jan 20;6(3):334-8. doi: 10.1021/ml500511m. eCollection 2015 Mar 12. PMID: 25815156; PMCID: PMC4360156.
Copy Download .nbib Format: NLM
Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin.

Biologics : targets & therapy

Onodera H, Urayama T, Hirota K, Maeda K, Kubota-Koketsu R, Takahashi K, Hagiwara K, Okuno Y, Ikuta K, Yunoki M.
PMID: 28331286
Biologics. 2017 Mar 10;11:23-30. doi: 10.2147/BTT.S123831. eCollection 2017.

Influenza viruses A/H1N1, A/H3N2, and B are known seasonal viruses that undergo annual mutation. Intravenous immunoglobulin (IVIG) contains anti-seasonal influenza virus globulins. Although the virus-neutralizing (VN) titer is an indicator of protective antibodies, changes in this titer over extended...

Cite
Onodera H, Urayama T, Hirota K, et al. Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin. Biologics. 2017;11:23-30doi: 10.2147/BTT.S123831.
Onodera, H., Urayama, T., Hirota, K., Maeda, K., Kubota-Koketsu, R., Takahashi, K., Hagiwara, K., Okuno, Y., Ikuta, K., & Yunoki, M. (2017). Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin. Biologics : targets & therapy, 1123-30. https://doi.org/10.2147/BTT.S123831
Onodera, Hiroyuki, et al. "Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin." Biologics : targets & therapy vol. 11 (2017): 23-30. doi: https://doi.org/10.2147/BTT.S123831
Onodera H, Urayama T, Hirota K, Maeda K, Kubota-Koketsu R, Takahashi K, Hagiwara K, Okuno Y, Ikuta K, Yunoki M. Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin. Biologics. 2017 Mar 10;11:23-30. doi: 10.2147/BTT.S123831. eCollection 2017. PMID: 28331286; PMCID: PMC5354529.
Copy Download .nbib Format: NLM
Syntheses and Potato Tuber-inducing Activity of Coronafacic Acid Analogues.

Bioscience, biotechnology, and biochemistry

Toshima H, Nara S, Ichihara A, Koda Y, Kikuta Y.
PMID: 27392555
Biosci Biotechnol Biochem. 1998;62(4):681-8. doi: 10.1271/bbb.62.681.

Coronafacic acid (1) is an acid component of coronatine, and has been isolated from several pathovars of Pseudomonas syringae. Syntheses of C6-non- and C6-alkyl-substituted analogues of 1 were accomplished via intramolecular 1,6-conjugate addition as the key step. Among them,...

Cite
Toshima H, Nara S, Ichihara A, et al. Syntheses and Potato Tuber-inducing Activity of Coronafacic Acid Analogues. Biosci Biotechnol Biochem. 1998;62(4):681-8doi: 10.1271/bbb.62.681.
Toshima, H., Nara, S., Ichihara, A., Koda, Y., & Kikuta, Y. (1998). Syntheses and Potato Tuber-inducing Activity of Coronafacic Acid Analogues. Bioscience, biotechnology, and biochemistry, 62(4), 681-8. https://doi.org/10.1271/bbb.62.681
Toshima, H, et al. "Syntheses and Potato Tuber-inducing Activity of Coronafacic Acid Analogues." Bioscience, biotechnology, and biochemistry vol. 62,4 (1998): 681-8. doi: https://doi.org/10.1271/bbb.62.681
Toshima H, Nara S, Ichihara A, Koda Y, Kikuta Y. Syntheses and Potato Tuber-inducing Activity of Coronafacic Acid Analogues. Biosci Biotechnol Biochem. 1998;62(4):681-8. doi: 10.1271/bbb.62.681. PMID: 27392555.
Copy Download .nbib Format: NLM
Hibernoma Showing High Uniform Accumulation on an .

Case reports in oncology

Kamata Y, Kikuta K, Susa M, Nishimoto K, Sasaki A, Kameyama K, Murakami K, Nakamura M, Matsumoto M, Morioka H.
PMID: 27721763
Case Rep Oncol. 2016 Aug 17;9(2):427-431. doi: 10.1159/000448240. eCollection 2016.

BACKGROUND: Hibernoma is a rare, benign, soft tissue tumor arising from brown fat that cannot be distinguished from other lipogenic tumors on computed tomography and magnetic resonance imaging (MRI) scans. On the other hand, the image of hibernoma on...

Cite
Kamata Y, Kikuta K, Susa M, et al. Hibernoma Showing High Uniform Accumulation on an . Case Rep Oncol. 2016;9(2):427-431doi: 10.1159/000448240.
Kamata, Y., Kikuta, K., Susa, M., Nishimoto, K., Sasaki, A., Kameyama, K., Murakami, K., Nakamura, M., Matsumoto, M., & Morioka, H. (2016). Hibernoma Showing High Uniform Accumulation on an . Case reports in oncology, 9(2), 427-431. https://doi.org/10.1159/000448240
Kamata, Yasuhiro, et al. "Hibernoma Showing High Uniform Accumulation on an ." Case reports in oncology vol. 9,2 (2016): 427-431. doi: https://doi.org/10.1159/000448240
Kamata Y, Kikuta K, Susa M, Nishimoto K, Sasaki A, Kameyama K, Murakami K, Nakamura M, Matsumoto M, Morioka H. Hibernoma Showing High Uniform Accumulation on an . Case Rep Oncol. 2016 Aug 17;9(2):427-431. doi: 10.1159/000448240. eCollection 2016. PMID: 27721763; PMCID: PMC5043362.
Copy Download .nbib Format: NLM
Individual variation in the sequence of ages at peak velocity in seven body dimensions.

American journal of human biology : the official journal of the Human Biology Council

Satake T, Malina RM, Tanaka S, Kikuta F.
PMID: 28548442
Am J Hum Biol. 1994;6(3):359-367. doi: 10.1002/ajhb.1310060311.

Seven body dimensions of 35 Japanese children, 15 boys and 20 girls, were measured longitudinally at six-monthly intervals from 9 through 15 years of age. Spline curves were fitted to each dimension to obtain age at peak velocity and...

Cite
Satake T, Malina RM, Tanaka S, et al. Individual variation in the sequence of ages at peak velocity in seven body dimensions. Am J Hum Biol. 1994;6(3):359-367doi: 10.1002/ajhb.1310060311.
Satake, T., Malina, R. M., Tanaka, S., & Kikuta, F. (1994). Individual variation in the sequence of ages at peak velocity in seven body dimensions. American journal of human biology : the official journal of the Human Biology Council, 6(3), 359-367. https://doi.org/10.1002/ajhb.1310060311
Satake, Takashi, et al. "Individual variation in the sequence of ages at peak velocity in seven body dimensions." American journal of human biology : the official journal of the Human Biology Council vol. 6,3 (1994): 359-367. doi: https://doi.org/10.1002/ajhb.1310060311
Satake T, Malina RM, Tanaka S, Kikuta F. Individual variation in the sequence of ages at peak velocity in seven body dimensions. Am J Hum Biol. 1994;6(3):359-367. doi: 10.1002/ajhb.1310060311. PMID: 28548442.
Copy Download .nbib Format: NLM
A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol.

Alzheimer's & dementia (New York, N. Y.)

Saito S, Kojima S, Oishi N, Kakuta R, Maki T, Yasuno F, Nagatsuka K, Yamamoto H, Fukuyama H, Fukushima M, Ihara M.
PMID: 29067312
Alzheimers Dement (N Y). 2016 Oct 27;2(4):250-257. doi: 10.1016/j.trci.2016.10.001. eCollection 2016 Nov.

INTRODUCTION: There are currently no effective treatments preventing conversion from mild cognitive impairment (MCI) to Alzheimer's disease. Cilostazol is a selective type-3 phosphodiesterase inhibitor that ameliorates accumulation of amyloid-β and has prevented cognitive decline in rodent models. Furthermore, cilostazol...

Cite
Saito S, Kojima S, Oishi N, et al. A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol. Alzheimers Dement (N Y). 2016;2(4):250-257doi: 10.1016/j.trci.2016.10.001.
Saito, S., Kojima, S., Oishi, N., Kakuta, R., Maki, T., Yasuno, F., Nagatsuka, K., Yamamoto, H., Fukuyama, H., Fukushima, M., & Ihara, M. (2016). A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol. Alzheimer's & dementia (New York, N. Y.), 2(4), 250-257. https://doi.org/10.1016/j.trci.2016.10.001
Saito, Satoshi, et al. "A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol." Alzheimer's & dementia (New York, N. Y.) vol. 2,4 (2016): 250-257. doi: https://doi.org/10.1016/j.trci.2016.10.001
Saito S, Kojima S, Oishi N, Kakuta R, Maki T, Yasuno F, Nagatsuka K, Yamamoto H, Fukuyama H, Fukushima M, Ihara M. A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol. Alzheimers Dement (N Y). 2016 Oct 27;2(4):250-257. doi: 10.1016/j.trci.2016.10.001. eCollection 2016 Nov. PMID: 29067312; PMCID: PMC5651350.
Copy Download .nbib Format: NLM
Correction for Okabayashi et al., Detection of Chikungunya Virus Antigen by a Novel Rapid Immunochromatographic Test.

Journal of clinical microbiology

Okabayashi T, Sasaki T, Masrinoul P, Chantawat N, Yoksan S, Nitatpattana N, Chusri S, Morales Vargas RE, Grandadam M, Brey PT, Soegijanto S, Mulyantno KC, Churrotin S, Kotaki T, Faye O, Faye O, Sow A, Sall AA, Puiprom O, Chaichana P, Kurosu T, Kato S, Kosaka M, Ramasoota P, Ikuta K.
PMID: 27016592
J Clin Microbiol. 2016 Apr;54(4):1173-4. doi: 10.1128/JCM.03073-15.

No abstract available.

Cite
Okabayashi T, Sasaki T, Masrinoul P, et al. Correction for Okabayashi et al., Detection of Chikungunya Virus Antigen by a Novel Rapid Immunochromatographic Test. J Clin Microbiol. 2016;54(4):1173-4doi: 10.1128/JCM.03073-15.
Okabayashi, T., Sasaki, T., Masrinoul, P., Chantawat, N., Yoksan, S., Nitatpattana, N., Chusri, S., Morales Vargas, R. E., Grandadam, M., Brey, P. T., Soegijanto, S., Mulyantno, K. C., Churrotin, S., Kotaki, T., Faye, O., Faye, O., Sow, A., Sall, A. A., Puiprom, O., Chaichana, P., Kurosu, T., Kato, S., Kosaka, M., Ramasoota, P., & Ikuta, K. (2016). Correction for Okabayashi et al., Detection of Chikungunya Virus Antigen by a Novel Rapid Immunochromatographic Test. Journal of clinical microbiology, 54(4), 1173-4. https://doi.org/10.1128/JCM.03073-15
Okabayashi, Tamaki, et al. "Correction for Okabayashi et al., Detection of Chikungunya Virus Antigen by a Novel Rapid Immunochromatographic Test." Journal of clinical microbiology vol. 54,4 (2016): 1173-4. doi: https://doi.org/10.1128/JCM.03073-15
Okabayashi T, Sasaki T, Masrinoul P, Chantawat N, Yoksan S, Nitatpattana N, Chusri S, Morales Vargas RE, Grandadam M, Brey PT, Soegijanto S, Mulyantno KC, Churrotin S, Kotaki T, Faye O, Faye O, Sow A, Sall AA, Puiprom O, Chaichana P, Kurosu T, Kato S, Kosaka M, Ramasoota P, Ikuta K. Correction for Okabayashi et al., Detection of Chikungunya Virus Antigen by a Novel Rapid Immunochromatographic Test. J Clin Microbiol. 2016 Apr;54(4):1173-4. doi: 10.1128/JCM.03073-15. PMID: 27016592; PMCID: PMC4809951.
Copy Download .nbib Format: NLM
Interventricular Septal Hematoma after Retrograde Intervention for a Chronic Total Occlusion of a Right Coronary Artery: Echocardiographic and Magnetic Resonance Imaging-Diagnosis and Follow-Up.

Case reports in medicine

Araki M, Murai T, Kanaji Y, Matsuda J, Usui E, Niida T, Ichijo S, Hamaya R, Kakuta T.
PMID: 26884768
Case Rep Med. 2016;2016:8514068. doi: 10.1155/2016/8514068. Epub 2016 Jan 14.

The reverse CART technique provides the potential to modify the retrograde procedure by improving the controlled movement of the retrograde wire and improve the success rates of percutaneous coronary intervention (PCI) of chronic total occlusion (CTO). Development of interventricular...

Cite
Araki M, Murai T, Kanaji Y, et al. Interventricular Septal Hematoma after Retrograde Intervention for a Chronic Total Occlusion of a Right Coronary Artery: Echocardiographic and Magnetic Resonance Imaging-Diagnosis and Follow-Up. Case Rep Med. 2016;2016:8514068doi: 10.1155/2016/8514068.
Araki, M., Murai, T., Kanaji, Y., Matsuda, J., Usui, E., Niida, T., Ichijo, S., Hamaya, R., & Kakuta, T. (2016). Interventricular Septal Hematoma after Retrograde Intervention for a Chronic Total Occlusion of a Right Coronary Artery: Echocardiographic and Magnetic Resonance Imaging-Diagnosis and Follow-Up. Case reports in medicine, 20168514068. https://doi.org/10.1155/2016/8514068
Araki, Makoto, et al. "Interventricular Septal Hematoma after Retrograde Intervention for a Chronic Total Occlusion of a Right Coronary Artery: Echocardiographic and Magnetic Resonance Imaging-Diagnosis and Follow-Up." Case reports in medicine vol. 2016 (2016): 8514068. doi: https://doi.org/10.1155/2016/8514068
Araki M, Murai T, Kanaji Y, Matsuda J, Usui E, Niida T, Ichijo S, Hamaya R, Kakuta T. Interventricular Septal Hematoma after Retrograde Intervention for a Chronic Total Occlusion of a Right Coronary Artery: Echocardiographic and Magnetic Resonance Imaging-Diagnosis and Follow-Up. Case Rep Med. 2016;2016:8514068. doi: 10.1155/2016/8514068. Epub 2016 Jan 14. PMID: 26884768; PMCID: PMC4738934.
Copy Download .nbib Format: NLM
Collagenous colitis appeared after 6-year administration of lansoprazole.

Clinical journal of gastroenterology

Sawada K, Fujiya M, Itabashi K, Suzuki Y, Kubo K, Nata T, Ueno N, Inaba Y, Moriichi K, Okamoto K, Ikuta K, Tanabe H, Mizukami Y, Takagi Y, Kohgo Y.
PMID: 26189901
Clin J Gastroenterol. 2010 Feb;3(1):18-21. doi: 10.1007/s12328-009-0126-4. Epub 2009 Nov 28.

Collagenous colitis (CC) is one of the causes of undefined watery diarrhea, which is histologically accompanied by thickening of the subepithelial collagen layer. CC associated with lansoprazole normally occurs within several weeks after initial administration, but no case presenting...

Cite
Sawada K, Fujiya M, Itabashi K, et al. Collagenous colitis appeared after 6-year administration of lansoprazole. Clin J Gastroenterol. 2009;3(1):18-21doi: 10.1007/s12328-009-0126-4.
Sawada, K., Fujiya, M., Itabashi, K., Suzuki, Y., Kubo, K., Nata, T., Ueno, N., Inaba, Y., Moriichi, K., Okamoto, K., Ikuta, K., Tanabe, H., Mizukami, Y., Takagi, Y., & Kohgo, Y. (2010). Collagenous colitis appeared after 6-year administration of lansoprazole. Clinical journal of gastroenterology, 3(1), 18-21. https://doi.org/10.1007/s12328-009-0126-4
Sawada, Koji, et al. "Collagenous colitis appeared after 6-year administration of lansoprazole." Clinical journal of gastroenterology vol. 3,1 (2010): 18-21. doi: https://doi.org/10.1007/s12328-009-0126-4
Sawada K, Fujiya M, Itabashi K, Suzuki Y, Kubo K, Nata T, Ueno N, Inaba Y, Moriichi K, Okamoto K, Ikuta K, Tanabe H, Mizukami Y, Takagi Y, Kohgo Y. Collagenous colitis appeared after 6-year administration of lansoprazole. Clin J Gastroenterol. 2010 Feb;3(1):18-21. doi: 10.1007/s12328-009-0126-4. Epub 2009 Nov 28. PMID: 26189901.
Copy Download .nbib Format: NLM
Functional evaluation of patients with surgically treated terrible triad of the elbow.

Acta ortopedica brasileira

Brigato RM, Mouraria GG, Kikuta FK, Coelho Sde P, Cruz MA, Zoppi A.
PMID: 26207090
Acta Ortop Bras. 2015 May-Jun;23(3):138-41. doi: 10.1590/1413-78522015230301008.

OBJECTIVES: To evaluate the functional outcome of patients with surgically treated terrible triad of the elbow.METHODS: A retrospective evaluation was performed using the MEPS score (Mayo Elbow Performance Score) of patients diagnosed with terrible triad of the elbow who...

Cite
Brigato RM, Mouraria GG, Kikuta FK, et al. Functional evaluation of patients with surgically treated terrible triad of the elbow. Acta Ortop Bras. 2015;23(3):138-41doi: 10.1590/1413-78522015230301008.
Brigato, R. M., Mouraria, G. G., Kikuta, F. K., Coelho, S. d. e. . P., Cruz, M. A., & Zoppi, A. (2015). Functional evaluation of patients with surgically treated terrible triad of the elbow. Acta ortopedica brasileira, 23(3), 138-41. https://doi.org/10.1590/1413-78522015230301008
Brigato, Rafael Mulatti, et al. "Functional evaluation of patients with surgically treated terrible triad of the elbow." Acta ortopedica brasileira vol. 23,3 (2015): 138-41. doi: https://doi.org/10.1590/1413-78522015230301008
Brigato RM, Mouraria GG, Kikuta FK, Coelho Sde P, Cruz MA, Zoppi A. Functional evaluation of patients with surgically treated terrible triad of the elbow. Acta Ortop Bras. 2015 May-Jun;23(3):138-41. doi: 10.1590/1413-78522015230301008. PMID: 26207090; PMCID: PMC4503605.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 696 entries